Alzheimer Disease

>

Latest News

Here are highlights from the week in Psychiatric Times.
The Week in Review: May 13-17

May 18th 2024

Here are highlights from the week in Psychiatric Times.

Alzheimer
Rolling Submission for Subcutaneous Lecanemab

May 15th 2024

This alters the course of developer Eisai's regulatory submission plans for lecanemab in the treatment of early Alzheimer disease.
FDA: Specific Fast Track Designation for Subcutaneous Formulation of Leqembi for Alzheimer Disease Needed for Rolling Review

April 3rd 2024

research
Have You Seen the Translating Research Into Practice Column?

April 2nd 2024

The experts weighed in on a wide variety of psychiatric issues for the March 2024 issue of Psychiatric Times.
From the Pages of Psychiatric Times: March 2024

March 30th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.